Observational studyPloS one2026
How frailty index impacts death in chronic kidney disease: A retrospective observational investigation.
Observational study in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe present study assessed the link between the frailty index and deaths from all causes or specific causes in patients with chronic kidney disease (CKD). The study data were derived from the National Health and Nutrition Examination Survey (NHANES) (1999-2018) involving 3262 CKD patients.
methodsWe used 53 multifaceted assessment instruments to measure frailty degree. Multivariable Cox regression analysis was performed, and hazard ratio (HR) and 95% confidence interval (CI) were calculated.
resultsThe median frailty index was 0.166 (interquartile range [IQR]: 0.01 to 0.665). During the median follow-up period of 9.4 years, a total of 1102 deaths from all causes were recorded, which included 196 cancer-related deaths and 402 heart disease-related deaths. Patients in the highest frailty index tertile showed more risk of dying from cardiovascular illness (adjusted HR 2.00, 95% CI 1.52-2.64), all causes (adjusted HR 1.81, 95% CI 1.54-2.13), and cancer (adjusted HR 1.59, 95% CI 1.09-2.33). The increase in cardiovascular-related deaths, all-cause-related deaths, and cancer-related deaths was 112% (P < 0.001), 85% (P < 0.001), and 72% (P < 0.001), respectively, for every logarithmic unit increase in the frailty index. These associations remained robust in stratified tests by sex, body mass index, age, race, diabetes history, hypertension status, and CKD stages.
conclusionsOur findings suggest that among patients with CKD, the frailty index is linked to both cause-specific and all-cause deaths. A key element of managing CKD should be frailty intervention as the frailty index may indicate prognosis in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.